Table 5.
PATIENTS’ CLINICAL MANAGEMENT AFTER 6 MONTHS FROM RADIOLOGIC ASSESSMENT | ||||||||
---|---|---|---|---|---|---|---|---|
Surgeon 1 | Surgeon 2 | |||||||
|
|
|||||||
Surgery | Neoadjuvant chemotherapy | Chemotherapy | Weighted kappa (95% CI) agreement | Surgery | Neoadjuvant chemotherapy | Chemotherapy | Weighted kappa (95% CI) agreement | |
MANAGEMENT AS PROPOSED AFTER READING OUTSIDE REPORTS | ||||||||
| ||||||||
Surgery | 6 | 2 | 10 | 3 | 2 | 6 | ||
Neoadjuvant chemotherapy | 1 | 0 | 8 | 0.426 (0,2489–0,6031) | 3 | 0 | 7 | 0.4136 (0,2149–0,6129) |
Chemotherapy | 0 | 0 | 38 | 1 | 0 | 43 | ||
| ||||||||
MANAGEMENT AS PROPOSED AFTER READING SECOND OPINION REPORTS | ||||||||
| ||||||||
Surgery | 3 | 0 | 1 | 5 | 0 | 3 | ||
Neoadjuvant chemotherapy | 3 | 2 | 7 | 0.6467 (0.4014–0.892) | 2 | 2 | 9 | 0.6262 (0.3954–0.857) |
Chemotherapy | 1 | 0 | 48 | 0 | 0 | 44 |